Bioabsorbable Stents companies

  • Report ID: 3612
  • Published Date: Jun 26, 2025
  • Report Format: PDF, PPT

Key Bioabsorbable Stents Market Players:

    The international bioabsorbable stents market is extremely fusion-based, with Abbott, Boston Scientific, and Medtronic jointly controlling almost 58% of the overall market. These key players have readily invested in polymer innovations, along with AI-powered designs. Meanwhile, regional players such as Lepu Medical and Meril Life Sciences effectively compete through cost-effective solutions. Besides, Germany’s Biotronik is leading in magnesium stents and has captured almost 12% of the market share. Hospital procurement deals as well as emerging market localization are two essential trends that are responsible for positively uplifting the market globally.

    Here is a list of key players operating in the global market:

    Company Name

    Country

    Market Share (2024)

    Industry Focus

    Abbott Laboratories

    U.S.

    22.8%

    Leading developer of Absorb GT1 bioresorbable scaffold

    Boston Scientific

    U.S.

    18.6%

    Focus on Synergy Megatron bioabsorbable stents

    Medtronic

    U.S.

    15.9%

    Resolute Onyx bioabsorbable polymer technology

    Biotronik

    Germany

    10.4%

    Magnesium-based absorbable stents (Magmaris)

    Elixir Medical

    U.S.

    8.8%

    DESyne BD novolimus-eluting bioabsorbable stent

    REVA Medical

    U.S.

    xx%

    Fantom sirolimus-eluting bioresorbable scaffold

    Terumo Corporation

    U.S./EU

    xx%

    Ultimaster bioabsorbable PLLA stents

    Meril Life Sciences

    India

    xx%

    MeRes100 bioresorbable stent for emerging markets

    Lepu Medical (China)

    China

    xx%

    Bioabsorbable PLLA stents for APAC markets

    MicroPort Scientific

    China

    xx%

    Firesorb bioresorbable sirolimus-eluting stent

    SMT (Sahajanand Medical)

    India

    xx%

    BioMime sirolimus-eluting bioabsorbable stent

    Cardionovum

    Germany

    xx%

    PLLA-based absorbable stents

    Balton (Poland)

    Poland

    xx%

    Bioabsorbable magnesium stents

    Alvimedica (Turkey)

    Turkey

    xx%

    Bioabsorbable coronary scaffolds

    OrbusNeich (Hong Kong)

    Hong Kong

    xx%

    COMBO dual-therapy bioabsorbable stent

    Below are the areas covered for each company in the bioabsorbable stents market:

    • Company Overview
    • Business Strategy
    • Key Product Offerings
    • Financial Performance
    • Key Performance Indicators
    • Risk Analysis
    • Recent Development
    • Regional Presence
    • SWOT Analysis

Browse key industry insights with market data tables & charts from the report:

Frequently Asked Questions (FAQ)

In the year 2024, the industry size of the bioabsorbable stents market was over USD 1.3 billion.

The market size for the bioabsorbable stents market is projected to reach USD 6.8 billion by the end of 2037 expanding at a CAGR of 17.2% during the forecast period i.e., between 2025-2037.

The major players in the market are Cardionovum, Balton, Alvimedica, OrbusNeich, and others.

In terms of the application segment, the coronary artery disease (CAD) segment is anticipated to garner the largest market share of 75.8% by 2037 and display lucrative growth opportunities during 2025-2037.

The market in North America is projected to hold the largest market share of 41.8% by the end of 2037 and provide more business opportunities in the future.
Inquiry Before Buying Request Free Sample PDF
footer-bottom-logos